← back to search

Kristine Torres‐Lockhart

Albert Einstein College of Medicine · US
Area of research
Molecular Biology · Genetics
Research interest
Research interests include BRCA gene mutations in cancer, Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors, and Opioid Use Disorder Treatment.
h-index
10
citations
1,115
works
56
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines
Journal of Hospital Medicine 2022cited by 38position: middledoi
PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition
Cancer Discovery 2012cited by 621position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Olga Rodríguez · Georgetown University1 papers (2012–2012)Hannah Snyder · George Washington University Hospital1 papers (2022–2022)Melissa B. Weimer · Yale New Haven Health System1 papers (2022–2022)Alyssa F. Peterkin · Boston University1 papers (2022–2022)Javier Cortés · Universidade Nova de Lisboa1 papers (2012–2012)Leif W. Ellisen · Harvard University1 papers (2012–2012)Celina García-García · Vall d'Hebron Institute of Oncology1 papers (2012–2012)Tauheed Zaman · San Francisco VA Medical Center1 papers (2022–2022)Susan L. Calcaterra · University of Colorado Hospital1 papers (2022–2022)Lei He · Shandong University of Technology1 papers (2012–2012)Marlene Martín · San Francisco General Hospital1 papers (2022–2022)Violeta Serra · Washington University in St. Louis1 papers (2012–2012)José Pérez · Instituto de Investigación Biomédica de Salamanca1 papers (2012–2012)Marta Guzmán · Hebron University1 papers (2012–2012)— · 1 papers (2022–2022)— · 1 papers (2022–2022)Aleix Prat · Clínica Girona1 papers (2012–2012)Shoshana J. Herzig · Beth Israel Deaconess Medical Center1 papers (2022–2022)Yasir H. Ibrahim · Royal National Orthopaedic Hospital1 papers (2012–2012)Pilar Antón · Vall d'Hebron Institute of Oncology1 papers (2012–2012)